Literature DB >> 28752280

Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

Waseem Hindieh1, Raymond Chan1, Harry Rakowski2.   

Abstract

PURPOSE OF REVIEW: This review discusses the complementary roles of echocardiography and cardiac magnetic resonance in the diagnosis and management of patients with hypertrophic cardiomyopathy (HCM). RECENT
FINDINGS: Imaging using novel echocardiographic techniques and cardiac magnetic resonance (CMR) imaging in HCM has demonstrated incremental utility in diagnosis and management guidance. Application of 3-D imaging has improved assessment of left ventricular (LV) mass and volume by echocardiography. Quantification of myocardial mechanics has shown promise for clarification of diagnosis, prognosis, and assessment of LV dysfunction. CMR permits 3-D tomographic characterization of cardiac structure and tissue characterization which has shown utility for assessing the diverse phenotypes in HCM and quantification of left ventricular fibrosis, an increasingly recognized poor prognostic marker. Non-invasive cardiac imaging remains central for the evaluation of HCM patients. An approach integrating echocardiography and CMR as complementary modalities allows for improved diagnostic and prognostic assessment.

Entities:  

Keywords:  Cardiac magnetic resonance; Echocardiography; Hypertrophic cardiomyopathy; Non-invasive imaging

Mesh:

Year:  2017        PMID: 28752280     DOI: 10.1007/s11886-017-0897-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  105 in total

1.  Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.

Authors:  Jose Angel Urbano-Moral; Ethan J Rowin; Martin S Maron; Andrew Crean; Natesa G Pandian
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792

2.  Detection of left ventricular regional relaxation abnormalities and asynchrony in patients with hypertrophic cardiomyopathy with the use of tissue Doppler imaging.

Authors:  T Oki; Y Mishiro; H Yamada; Y Onose; M Matsuoka; T Wakatsuki; T Tabata; S Ito
Journal:  Am Heart J       Date:  2000-03       Impact factor: 4.749

3.  Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.

Authors:  Mohamed F A Aly; Wessel P Brouwer; Sebastiaan A Kleijn; Albert C van Rossum; Otto Kamp
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-30       Impact factor: 2.357

4.  Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study.

Authors:  R A Nishimura; C P Appleton; M M Redfield; D M Ilstrup; D R Holmes; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Diastolic myocardial mechanics in hypertrophic cardiomyopathy.

Authors:  Shemy Carasso; Hua Yang; Anna Woo; Michal Jamorski; E Douglas Wigle; Harry Rakowski
Journal:  J Am Soc Echocardiogr       Date:  2010-02       Impact factor: 5.251

6.  Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.

Authors:  H G Klues; W C Roberts; B J Maron
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

7.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

8.  Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.

Authors:  Paola Melacini; Cristina Basso; Annalisa Angelini; Chiara Calore; Fabiana Bobbo; Barbara Tokajuk; Nicoletta Bellini; Gessica Smaniotto; Mauro Zucchetto; Sabino Iliceto; Gaetano Thiene; Barry J Maron
Journal:  Eur Heart J       Date:  2010-05-31       Impact factor: 29.983

9.  Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.

Authors:  Christian Prinz; Maria Schwarz; Ivan Ilic; Kai Thorsten Laser; Roman Lehmann; Eva-Maria Prinz; Thomas Bitter; Jürgen Vogt; Frank van Buuren; Nikola Bogunovic; Dieter Horstkotte; Lothar Faber
Journal:  Can J Cardiol       Date:  2012-06-30       Impact factor: 5.223

10.  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Iacopo Olivotto; Pietro Bellone; Maria Rosa Conte; Franco Cecchi; Björn P Flygenring; Susan A Casey; Thomas E Gohman; Sergio Bongioanni; Paolo Spirito
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

View more
  6 in total

1.  Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?

Authors:  Paco E Bravo
Journal:  J Nucl Cardiol       Date:  2018-05-14       Impact factor: 5.952

2.  Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA.

Authors:  Daniele Massera; Robyn L McClelland; Bharath Ambale-Venkatesh; Antoinette S Gomes; W Gregory Hundley; Nadine Kawel-Boehm; Kihei Yoneyama; David S Owens; Mario J Garcia; Mark V Sherrid; Jorge R Kizer; Joao A C Lima; David A Bluemke
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

Review 3.  Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.

Authors:  Radu Ovidiu Rosu; Ana Lupsor; Alexandru Necula; Gabriel Cismaru; Simona Sorana Cainap; Daniela Iacob; Cecilia Lazea; Andrei Cismaru; Alina Gabriela Negru; Dana Pop; Gabriel Gusetu
Journal:  Diagnostics (Basel)       Date:  2022-02-14

Review 4.  Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy.

Authors:  Haneen Ismail; Andrew J Bradley; Jannet F Lewis
Journal:  Front Cardiovasc Med       Date:  2022-08-03

5.  Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy.

Authors:  Maedeh Sharifian; Nahid Rezaeian; Sanaz Asadian; Ali Mohammadzadeh; Ali Nahardani; Kianosh Kasani; Yaser Toloueitabar; Ali Mohammad Farahmand; Leila Hosseini
Journal:  Cardiol Res Pract       Date:  2021-05-24       Impact factor: 1.866

6.  Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers.

Authors:  Ândrea Chaves-Markman; Manuel Markman; Marcelo Antônio O Santos-Veloso; Lucas S Bezerra; Dário C Sobral Filho; Brivaldo Markman Filho
Journal:  Cureus       Date:  2020-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.